Table 3.
Characteristics of Patients With Documented COVID-19 by Vital Status
| Died | Survived | |
|---|---|---|
| No. of patients | 109 (24.9%) | 329 (75.1%) |
| Age, y | 70.8 ± 10.3 (70.5) | 63.3 ± 13.6 (64.2) |
| <50 y | 2 (1.8%) | 52 (15.8%) |
| 51-59 y | 17 (15.6%) | 74 (22.5%) |
| 60-69 y | 34 (31.2%) | 90 (27.4%) |
| 70-79 y | 33 (30.3%) | 81 (24.6%) |
| 80+ y | 23 (21.1%) | 32 (9.7%) |
| Male sex | 70 (64.2%) | 194 (59.0%) |
| Race | ||
| White | 36 (33.0%) | 79 (24.0%) |
| Black | 56 (51.4%) | 197 (60.0%) |
| Other/not stated | 17(15.6%) | 53(16.1%) |
| Ethnicity | ||
| Hispanic | 10 (9.2%) | 27 (8.2%) |
| Non-Hispanic | 87 (79.8%) | 248 (75.4%) |
| Not stated | 12 (11.0%) | 54 (16.4%) |
| Dialysis vintage, mo | 63.4 ± 61.6 (43.6) | 53.6 ± 53.0 (39.3) |
| <3 mo | 5 (4.6%) | 24 (7.3%) |
| 3-12 mo | 10 (9.2%) | 41 (12.5%) |
| 12-36 mo | 28(25.7%) | 92(28.0%) |
| >36 mo | 66(60.6%) | 172(52.3%) |
| Home dialysis modality | 3(2.8%) | 15(4.6%) |
| Central venous catheter | 30(27.5%) | 74(22.5%) |
| Congregate setting | 65(59.6%) | 174(52.9%) |
| Urban clinic | 103(94.5%) | 309(93.9%) |
| Albumin, g/dL | 3.7 ± 0.5 (3.7) | 3.8 ± 0.4 (3.9) |
| <3.5 g/dL | 28 (25.7%) | 56 (17.0%) |
| 3.5-3.9 g/dL | 45 (41.3%) | 139 (42.3%) |
| ≥4 g/dL | 36 (33.0%) | 121 (36.8%) |
| Body mass index, kg/m2 | 28.9 ± 6.9 (26.9) | 29.1 ± 7.7 (27.5) |
| Tobacco use | 19 (17.4%) | 53 (16.1%) |
| ACEI/ARBs | 28 (25.7%) | 113 (34.4%) |
| Inhaled respiratory agent | 35 (32.4%) | 74 (22.5%) |
| Corticosteroid | 12 (11.0%) | 15 (4.6%) |
| Pneumococcal vaccination | 94 (86.2%) | 291 (88.5%) |
| 2019 Influenza vaccination | 88 (80.7%) | 274 (83.3%) |
| No. of comorbidities | 3.7 ± 2.2 (3.0) | 3.2 ± 1.8 (3.0) |
| Comorbidity | ||
| Diabetes mellitus | 75 (68.8%) | 231 (70.2%) |
| Hypertension | 79 (72.5%) | 267 (81.2%) |
| CHF | 37 (33.9%) | 67 (20.4%) |
| Atherosclerotic heart disease | 33 (30.3%) | 84 (25.8%) |
| Stroke | 13 (11.9%) | 38 (11.6%) |
| Other Cardiovascular | 53 (48.6%) | 109 (33.1) |
| COPD | 19 (17.4%) | 47 (14.3%) |
| PVD | 29 (26.6%) | 39 (11.9%) |
| Amputation history | 5 (4.6%) | 9 (2.7%) |
| Assistance with ADL | 2 (1.8%) | 2 (0.6%) |
| Cancer history | 11 (10.1%) | 25 (7.6%) |
| Alcohol abuse history | 13 (11.9%) | 43 (13.1%) |
| Drug abuse history | 5 (4.6%) | 24 (7.3%) |
| Wheelchair use | 8 (7.3%) | 7 (2.1%) |
Data are mean ± SD (median) or number (%). Age is reported in years and dialysis duration (vintage) in months. Race and ethnicity are independent of each other.
Abbreviations: ADL, activities of daily living; ARB, angiotensin receptor blocker; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; PVD, peripheral vasculardisease.